Cargando…
Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System
Advanced glycation end products (AGEs) represent a set of molecules that contribute directly to the initiation and aggravation of diseases associated with ageing. AGEs are produced by the reaction between reducing sugars (or α-dicarbonyl compounds), proteins, and amino acid residues. Previous in vit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164639/ https://www.ncbi.nlm.nih.gov/pubmed/30111701 http://dx.doi.org/10.3390/biomedicines6030088 |
_version_ | 1783359648539082752 |
---|---|
author | Marques, Samuel Trevisan, Teresa Maia, Carlos Breuer, Andrea Owen, Robert W. |
author_facet | Marques, Samuel Trevisan, Teresa Maia, Carlos Breuer, Andrea Owen, Robert W. |
author_sort | Marques, Samuel |
collection | PubMed |
description | Advanced glycation end products (AGEs) represent a set of molecules that contribute directly to the initiation and aggravation of diseases associated with ageing. AGEs are produced by the reaction between reducing sugars (or α-dicarbonyl compounds), proteins, and amino acid residues. Previous in vitro methods using non-enzymatic procedures described in the literature require an incubation period of 1–3 weeks to generate AGEs. In this study, the reaction time for the formation of AGEs (48 and 3 h) was significantly reduced by adaptation of methods previously described in the literature and coupling them to the free radical generation system termed hypoxanthine/xanthine oxidase assay. The incorporation of this assay into the experimental system accelerated the production of AGEs as a result of the formation of reactive oxygen species (ROS), as shown by increased fluorescence. The capacity of different classes of chemical compounds (aminoguanidine, chlorogenic acid, rutin, and methanol extracts of Hancornia speciosa Gomes) to inhibit protein glycation by acting as scavenging agents of α-dicarbonyl species was evaluated. Aminoguanidine and, especially, rutin identified in the leaf extracts of H. speciosa Gomes showed a high capacity to act as scavengers of reactive carbonyl species RCS-trapping, resulting in the inhibition of AGEs formation. |
format | Online Article Text |
id | pubmed-6164639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61646392018-10-11 Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System Marques, Samuel Trevisan, Teresa Maia, Carlos Breuer, Andrea Owen, Robert W. Biomedicines Article Advanced glycation end products (AGEs) represent a set of molecules that contribute directly to the initiation and aggravation of diseases associated with ageing. AGEs are produced by the reaction between reducing sugars (or α-dicarbonyl compounds), proteins, and amino acid residues. Previous in vitro methods using non-enzymatic procedures described in the literature require an incubation period of 1–3 weeks to generate AGEs. In this study, the reaction time for the formation of AGEs (48 and 3 h) was significantly reduced by adaptation of methods previously described in the literature and coupling them to the free radical generation system termed hypoxanthine/xanthine oxidase assay. The incorporation of this assay into the experimental system accelerated the production of AGEs as a result of the formation of reactive oxygen species (ROS), as shown by increased fluorescence. The capacity of different classes of chemical compounds (aminoguanidine, chlorogenic acid, rutin, and methanol extracts of Hancornia speciosa Gomes) to inhibit protein glycation by acting as scavenging agents of α-dicarbonyl species was evaluated. Aminoguanidine and, especially, rutin identified in the leaf extracts of H. speciosa Gomes showed a high capacity to act as scavengers of reactive carbonyl species RCS-trapping, resulting in the inhibition of AGEs formation. MDPI 2018-08-15 /pmc/articles/PMC6164639/ /pubmed/30111701 http://dx.doi.org/10.3390/biomedicines6030088 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marques, Samuel Trevisan, Teresa Maia, Carlos Breuer, Andrea Owen, Robert W. Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title_full | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title_fullStr | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title_full_unstemmed | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title_short | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
title_sort | improved methods for the rapid formation and prevention of advanced glycation end products (ages) in vitro by coupling to the hypoxanthine/xanthine oxidase assay system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164639/ https://www.ncbi.nlm.nih.gov/pubmed/30111701 http://dx.doi.org/10.3390/biomedicines6030088 |
work_keys_str_mv | AT marquessamuel improvedmethodsfortherapidformationandpreventionofadvancedglycationendproductsagesinvitrobycouplingtothehypoxanthinexanthineoxidaseassaysystem AT trevisanteresa improvedmethodsfortherapidformationandpreventionofadvancedglycationendproductsagesinvitrobycouplingtothehypoxanthinexanthineoxidaseassaysystem AT maiacarlos improvedmethodsfortherapidformationandpreventionofadvancedglycationendproductsagesinvitrobycouplingtothehypoxanthinexanthineoxidaseassaysystem AT breuerandrea improvedmethodsfortherapidformationandpreventionofadvancedglycationendproductsagesinvitrobycouplingtothehypoxanthinexanthineoxidaseassaysystem AT owenrobertw improvedmethodsfortherapidformationandpreventionofadvancedglycationendproductsagesinvitrobycouplingtothehypoxanthinexanthineoxidaseassaysystem |